These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36732357)

  • 1. Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon.
    Kobayashi T; Matsui Y; Miki H; Hatta M; Ishida M; Satake H; Sekimoto M
    Surg Case Rep; 2023 Feb; 9(1):17. PubMed ID: 36732357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
    Agaimy A; Rau TT; Hartmann A; Stoehr R
    Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INI1-negative colorectal undifferentiated carcinoma with rhabdoid features and postoperative rapidly growing liver metastases: a case report and review of the literature.
    Kojima M; Miyake T; Ueki T; Ohta H; Kushima R; Shiohara M; Mizuta H; Iida H; Yamaguchi T; Kaida S; Takebayashi K; Maehira H; Nishina Y; Shimizu T; Mekata E; Tani M
    Surg Case Rep; 2021 Apr; 7(1):104. PubMed ID: 33903966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature.
    Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D
    World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
    Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
    Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
    Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
    Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report.
    Ashitomi Y; Yano M; Kono M; Suzuki T; Kawamura I; Okazaki S; Kamio Y; Hachiya O; Urano Y; Motoi F
    Surg Case Rep; 2020 Aug; 6(1):196. PubMed ID: 32748092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCB1/INI1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature.
    Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P
    Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1/INI1-Deficient Extrarenal Rhabdoid Tumor: A Case Report of a Rare and Aggressive Soft Tissue Sarcoma.
    Parker NA; Al-Obaidi A; Lalich D; Deutsch JM
    Cureus; 2020 May; 12(5):e8273. PubMed ID: 32467817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.
    Yoshida K; Fujiwara Y; Goto Y; Kohno T; Yoshida A; Tsuta K; Ohe Y
    BMC Cancer; 2018 Apr; 18(1):398. PubMed ID: 29625594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
    Agaimy A
    Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant presentation of a SMARCB1-deficient, anterior cranial fossa tumor in adult.
    Levitan I; Fichman S; Laviv Y
    Surg Neurol Int; 2020; 11():195. PubMed ID: 32754366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1/INI1/BAF47- deficient pleural malignant mesothelioma with rhabdoid features.
    Kimura N; Hasegawa M; Hiroshima K
    Pathol Int; 2018 Feb; 68(2):128-132. PubMed ID: 29316066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
    Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
    Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
    Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
    Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMARCB1/INI1-deficient tumors of adulthood.
    Parker NA; Al-Obaidi A; Deutsch JM
    F1000Res; 2020; 9():662. PubMed ID: 33796273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.